Portfolio comparison
Transkaryotic Therapies Inc vs Samsung Electronics Co
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Transkaryotic Therapies Inc
Patents indexed
1
Year range
2003
Most recent
2003
biotechpharmaceutical
Top Patents1 enriched
US 6531124· 2003
How to Use Modified Cells to Produce Insulin-Regulating Proteins in the Body
Activity by Decade
2000s1
Company B
Samsung Electronics Co
Patents indexed
2
Year range
2019 – 2022
Most recent
2022
softwareai_mltelecommunicationsecommercefinance
Top Patents2 enriched
US 11507851· 2022
How AI Connects Different Databases Using Knowledge Graphs
US 10307129· 2019
Fixing Blurry Tomography Scans from Patient Movement
Activity by Decade
2010s1
2020s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.